Objective: To determine whether an educational programme could reduce the i
nappropriate use of albumin.
Study design and setting: A hospital albumin working group (San Carlos Clin
ical Hospital, Madrid, Spain) developed local guidelines for albumin prescr
ibing. After the guidelines were disseminated, all albumin prescriptions we
re analysed according to these guidelines. Physicians who prescribed albumi
n for indications other than those in the guidelines were selected for a pe
rsonalised face-to-face educational programme with a clinical pharmacologis
ts. Adherence to the guidelines was then evaluated compared with an observa
tional period with success being measured in terms of quality of prescribin
g and economic consequences. The effects of the intervention were assessed
again during the intervention (7 months) and after the intervention tin the
first 5-month period and in the subsequent year).
Main outcomes measures and results: in the observational period, consumptio
n was centralised in medical services and nearly 76% of prescriptions for a
lbumin were inappropriate. During the intervention, the percentage of inapp
ropriate albumin prescribing decreased to 38.8%. Albumin consumption decrea
sed from 444 vials/month during the observational period to 249 vials/month
during the intervention, and although the average monthly consumption incr
eased slightly during the 17 months following the intervention, it was simi
lar to that immediately after the intervention.
Differences in albumin consumption and quality improvement between the obse
rvational period and during the intervention were statistically significant
(p < 0.00001). These results led to cost savings of nearly 30% during the
intervention and in the follow-up period.
Conclusions: This educational programme improved the quality of albumin pre
scribing and controlled local expenses related to albumin use in a general
hospital.